Christine Langer
Overview
Explore the profile of Christine Langer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suchan M, Wuerdemann N, Wagner S, Langer C, Arens C, Johannsen J, et al.
Oral Oncol
. 2025 Feb;
162:107209.
PMID: 39893876
Introduction: Subgroups with a poorer prognosis exist among patients with human papillomavirus positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC). This study aims to identify histological and genetic differences within HPV-positive...
2.
Cekay M, Arndt P, Franken J, Wilhelm J, Pullamsetti S, Roller F, et al.
BMJ Open Respir Res
. 2024 Aug;
11(1).
PMID: 39179271
Background: Cancer is one of the leading causes of death worldwide, and cardiopulmonary comorbidities may further adversely affect cancer prognosis. We recently described lung cancer-associated pulmonary hypertension (PH) as a...
3.
Apnoeic oxygenation with high flow nasal oxygen for interventional surgery of the larynx and pharynx
Langer C, Wittekindt C, Arens C, Kabisch S
Eur Arch Otorhinolaryngol
. 2024 May;
281(9):4889-4895.
PMID: 38750174
Background: Highflow nasal cannula oxygen (HFNO) is known to be used for noninvasive oxygenation in intensive care patients but it has rarely been used in airway management for elective surgery...
4.
Klasen C, Wuerdemann N, Rothbart P, Prinz J, Eckel H, Suchan M, et al.
BMC Cancer
. 2023 Nov;
23(1):1054.
PMID: 37919644
Background: Oropharyngeal squamous cell carcinoma (OPSCC) is the only subgroup of head neck cancer that presents with an increased incidence. Gender-specific studies in other cancer entities have revealed differences in...
5.
Klein S, Wuerdemann N, Demers I, Kopp C, Quantius J, Charpentier A, et al.
NPJ Digit Med
. 2023 Aug;
6(1):152.
PMID: 37598255
Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell cancer (OPSCC) represents an OPSCC subgroup with an overall good prognosis with a rising incidence in Western countries. Multiple lines of evidence suggest...
6.
Poumbourios P, Langer C, Boo I, Zakir T, Center R, Akerman A, et al.
PLoS Pathog
. 2023 May;
19(5):e1010981.
PMID: 37200378
The spike (S) glycoprotein of SARS CoV-2 is the target of neutralizing antibodies (NAbs) that are crucial for vaccine effectiveness. The S1 subunit binds ACE2 while the S2 subunit mediates...
7.
Wagner S, Langer C, Wuerdemann N, Reiser S, Abing H, Pons-Kuhnemann J, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046829
Background: Human papillomavirus (HPV) status is the most important predictor of survival in oropharyngeal squamous cell carcinoma (OPSCC). In patients with cervical lymph node metastases of squamous cell carcinoma of...
8.
Krauss C, Wagner S, Klussmann J, Pons-Kuhnemann J, Arens C, Langer C, et al.
Laryngorhinootologie
. 2023 Jan;
102(7):e3.
PMID: 36720224
No abstract available.
9.
Krauss C, Wagner S, Klussmann J, Pons-Kuhnemann J, Arens C, Langer C, et al.
Laryngorhinootologie
. 2022 Dec;
102(7):512-520.
PMID: 36543220
Objective: Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and...
10.
Sharma S, Schartinger V, Wuerdemann N, Langer C, Mollenhoff K, Collin L, et al.
Oncol Res Treat
. 2022 Jul;
45(10):561-567.
PMID: 35850111
Introduction: The oncogenic human papillomaviruses (HPV) types 16 and 18 contribute to more than 73% cases of all HPV-related cancers and commonly affect the anogenital and head and neck region,...